IntelliCell BioSciences Announces James R. Andrews, M.D. Has Joined Its Medical Advisory Board

NEW YORK--(BUSINESS WIRE)--IntelliCell BioSciences, Inc. (OTCQB: SVFC.PK) ("IntelliCell" or the "Company"), James R. Andrews, M.D. and Joshua Hackel, M.D. of the Andrews Institute of Orthopedic and Sports Medicine in Gulf Breeze, FL have joined IntelliCell BioSciences Medical Advisory Board. Dr. Steven Victor, CEO, of IntelliCell BioSciences said, "We are extremely excited to welcome Dr. Andrews and Dr. Hackel as scientific advisors to our company. In addition, we are exploring the establishment of an IntelliCell Center of Excellence at the Andrews Institute to conduct clinical research in the use of Stromal Vascular Fracture SVF cells manufactured through our propriety non-enzymatic process."